We also explained the relationship between Bregs and disease status in MM that ratios of BM-derived Bregs within CD19+ B cells were significantly higher in patients with NDMM than in those on maintenance therapy after response (17). The gene discussed is CD19; the disease is Miyoshi myopathy.